Retinal nerve fiber layer thickness in parkinson disease

Journal of Neuro-Ophthalmology

Volumn 33, Issue 1, 2013, Pages 62-65

  Kirbas, Serkan ^a   Turkyilmaz, Kemal ^a   Tufekci, Ahmet ^a   Durmus, Mustafa ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RETINAL NERVE FIBER LAYER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TEMPORAL LOBE; VISUAL IMPAIRMENT;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84874118157     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3182701745     Document Type: Article

References (15)

1. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson's disease. Brain. 2009;132:1128-1145
2. Miller RL, Kracke JM, Sun GY, Sun AY. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res. 2009;34:55-65
3. Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease. Neurology. 2004;62:177-180
4. Rodnitzky RL. Visual dysfunction in Parkinson's disease. Clin Neurosci. 1998;5:102-106
5. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011:21;24-29
6. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 1997:37;3509-3529
7. Aeker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010:4;1427-1432
8. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008;116:137-146
9. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44:2793-2797
10. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: Overview and research. J Neural Transm Suppl. 1993;39:165-172
11. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Ciladi N, Holloway RC, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord. 2004;19:1020-1023
12. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13:296-302
13. Malmfors T. Evidence of adrenergic neurons with synaptic terminals in the retina of rat demonstrated with fluorescence and electron microscopy. Acta Physiol Scand. 1963;58: 99-100
14. Guo L, Duggan J, Corderio MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res. 2010;7:3-14
15. Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E. MPTP produces reversible disappearance of thyrosine hydroxylase containing retinal amacrine cells. Brain Res. 1990;527:21-31